Clinical Efficacy and Mechanism of Heiguteng Zhuifeng Huoluo Capsule in Treating Rheumatoid Arthritis

GU Jin-hua; WU Ya-lin; CHEN Wen-lin; ZHAO Ping

doi:10.13422/j.cnki.syfjx.2018030180

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy and Mechanism of Heiguteng Zhuifeng Huoluo Capsule in Treating Rheumatoid Arthritis

更新时间：2024-01-04

- Clinical Efficacy and Mechanism of Heiguteng Zhuifeng Huoluo Capsule in Treating Rheumatoid Arthritis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 3, Pages: 180-184(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2018030180
  CLC： R259
- Published：2018
- 稿件说明：
移动端阅览
GU Jin-hua, WU Ya-lin, CHEN Wen-lin, et al. Clinical Efficacy and Mechanism of Heiguteng Zhuifeng Huoluo Capsule in Treating Rheumatoid Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(3): 180-184.
DOI：

GU Jin-hua, WU Ya-lin, CHEN Wen-lin, et al. Clinical Efficacy and Mechanism of Heiguteng Zhuifeng Huoluo Capsule in Treating Rheumatoid Arthritis[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(3): 180-184. DOI： 10.13422/j.cnki.syfjx.2018030180.

摘要

目的：探讨黑骨藤追风活络胶囊治疗风寒湿痹型类风湿关节炎的临床疗效及深层作用机制。方法：将80例宜宾市第二人民医院确诊的风寒湿痹型类风湿关节炎患者随机分为观察组与对照组，各40例，对照组给予口服洛索洛芬钠，60 mg/次，3次/d，氨甲蝶呤（MTX）7.5~2 mg/次，1次/周；观察组在口服洛索洛芬钠基础上加用黑骨藤追风活络胶囊治疗，0.9 g/次，3次/d，连续服药3个月；采用视觉模拟评分法（VAS）观察治疗前后关节压痛数、关节肿胀数、关节肿胀指数、双手平均握力、静息痛、晨僵时间变化；酶联免疫吸附试验（ELISA）检测两组患者治疗前后血清中血沉（ERS），C-反应蛋白（CRP），类风湿因子（RF）含量变化；ELISA法检测两组患者治疗前后关节液中白细胞介素（IL）-17A，IL-18，IL-27含量变化；实时荧光定量聚合酶链式反应（Real-time PCR）检测两组患者治疗前后关节液微小mRNA （microRNA，miR）-146a，miR-16表达变化。结果：经Ridit分析，观察组临床疗效优于对照组（P<0.05）；观察组治疗后关节压痛数、关节肿胀数、关节肿胀指数、双手平均握力、静息痛、晨僵时间改善程度均显著优于对照组（P<0.01）；观察组治疗后血清ERS，CRP，RF含量明显低于对照组；观察组治疗后关节液IL-17A，IL-18，IL-27含量及miR-146a，miR-16表达明显低于对照组。结论：黑骨藤追风活络胶囊可能通过降低miR-146a，miR-16表达，调控炎症因子释放，进而减轻自身免疫因子的表达，从而达到改善风寒湿痹型RA患者体征及症状的作用。

Abstract

Objective:To explore the clinical efficacy and deep mechanism of Heiguteng Zhuifeng Huoluo capsule in treatment of rheumatoid arthritis. Method:The 80 patients with rheumatoid arthritis diagnosed in The Second People's Hospital of Yibin were randomly divided into observation group (40 cases) and control group (40 cases). The control group was given with oral loxoprofen sodium 60 mg/time

3 times/d; methotrexate (MTX) 7.5-2 mg/times

1 time/week; the observation group was given with additional Heiguteng Zhuifeng Huoluo capsule based on oral loxoprofen sodium

0.9 g/time

3 times/d

for continuous 3 months. The changes of joint tenderness

joint swelling

joint swelling index

average grip strength

rest pain and morning stiffness time were observed by using visual analogue scale (VAS) before and after treatment. The levels of erythrocyte sedimentation rate (ERS)

C-reactive protein (CRP) and rheumatoid factor (RF) were measured by enzyme linked immunosorbent assay (ELISA) before and after treatment. The changes of interleukin (IL)-17A

IL-18 and IL-27 in synovial fluid were measured by ELISA. Real-time PCR was used to detect the expression levels of microRNA (miR)-146a and miR-16 in the synovial fluid before and after treatment. Result:The clinical efficacy of the observation group was better than that of the control group (P <0.05) by Ridit analysis. The number of joint tenderness

joint swelling

joint swelling index

average grip strength

rest rest pain and morning stiffness were significantly better in observation group than those in control group (P <0.01). The expression levels of ERS

CRP and RF in serum of the observation group were significantly lower than those in control group

and the expression levels of IL-17A

IL-18

IL-27

miR-146a and miR-16 in synovial fluid of observation group were also significantly lower than those in control group. Conclusion:Heiguteng Zhuifeng Huoluo capsule can reduce the expression of miR-146a and miR-16

regulate the release of inflammatory factors

and reduce the expression of autoimmune factors

so as to improve the signs and symptoms of rheumatoid arthritis.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Editorial Explanation of Guidelines for Establishing Animal Models of Rheumatoid Arthritis with Cold-dampness Obstruction Syndrome and Dampness-heat Obstruction Syndrome

Guidelines for Establishing Animal Models of Rheumatoid Arthritis with Cold-dampness Obstruction Syndrome and Dampness-heat Obstruction Syndrome

Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome

Pathogenesis and Traditional Chinese Medicine Treatment of Rheumatoid Arthritis Based on Theory of "Harmful Hyperactivity and Responding Inhibition"

Curative Effect of Tripterygium wilfordii Polyglycoside Tablets in Treatment of Rheumatoid Arthritis in Real World Based on Propensity Score Matching

Related Author

LIN Na

ZHANG Yanqiong

XIAO Changhong

XU Shijun

MAO Xia

Representation Preparation Group

TU Shenghao

SUN Jianning

Related Institution

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

Southern Medical University Hospital of Integrated Chinese and Western Medicine

Tongji Hospital， Tongji Medical College of Huazhong University of Science and Technology

School of Chinese Materia Medica， Beijing University of Chinese Medicine

School of Pharmacy，Chengdu University of Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰